1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Slow gait, white matter characteristics, and prior 10-year interleukin-6 levels in older adults

      research-article
      , MD, PhD, FRCPC , , PhD, , MD, MPH, , MD, , PhD, , PhD, , MD, , MD, MPH, , MD, MPH
      Neurology
      Lippincott Williams & Wilkins

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective:

          To examine the relationship between gait speed and prior 10 years interleukin-6 (IL-6) burden in older adults. We then assessed whether white matter characteristics influence this relationship.

          Methods:

          In 179 community-dwelling older adults, gait speed was assessed on an automated walkway and serum IL-6 was assayed on ELISA. Concurrently, white matter characteristics were assessed on MRI by quantifying volume of white matter hyperintensities (WMH), a marker of small vessel disease, and normal-appearing white matter on fractional anisotropy (NAWM-FA), a marker of axonal integrity. IL-6 was assayed at regular intervals at gait assessment and over the prior 10 years and estimates of sustained 10-year IL-6 exposure and the rate of change in IL-6 over 10 years were obtained. Multivariate linear regressions were used to examine the relationships among sustained IL-6 exposure, rate of change in IL-6, gait speed, and white matter characteristics.

          Results:

          In this sample (age 83 years, 58% female, 41% black, gait speed 0.9 m/s), higher sustained IL-6 levels, but not the rate of change in IL-6 or IL-6 at gait assessment, was significantly related to slower gait (β = −0.27, p < 0.001) and to higher WMH (β = 0.23, p = 0.002), but not NAWM-FA, withstanding covariate adjustments. WMH accounted for 30% attenuation in the relationship between higher sustained IL-6 levels and slower gait speed ( p = 0.043) in the mediation analyses.

          Conclusions:

          Sustained exposure to high IL-6 over 10 years rather than the rate of change in IL-6 or an isolated high IL-6 level may adversely affect gait speed by influencing cerebral WMH.

          Related collections

          Author and article information

          Contributors
          Journal
          Neurology
          Neurology
          neurology
          neur
          neurology
          NEUROLOGY
          Neurology
          Lippincott Williams & Wilkins (Hagerstown, MD )
          0028-3878
          1526-632X
          08 November 2016
          08 November 2017
          : 87
          : 19
          : 1993-1999
          Affiliations
          From the Division of Geriatric Medicine and Gerontology, Department of Medicine (N.K.N.), Department of Neurology (O.L.L.) and the Pittsburgh Alzheimer's Disease Research Center (O.L.L., N.K.N.), University of Pittsburgh School of Medicine, and Department of Epidemiology, Graduate School of Public Health (R.M.B., G.L., A.B.N., C.R.), University of Pittsburgh, PA; Sticht Center on Aging (S.K.), Wake Forest School of Medicine, Winston-Salem, NC; Department of Psychiatry (K.Y.), University of California at San Francisco; and the Longitudinal Studies Section (S.A.S.), Translational Gerontology Branch, National Institute on Aging, Baltimore, MD.
          Author notes
          Correspondence to Dr. Nadkarni: nkn3@ 123456pitt.edu

          Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

          Article
          PMC5109955 PMC5109955 5109955 NEUROLOGY2016723890
          10.1212/WNL.0000000000003304
          5109955
          27733566
          99edc5a6-c065-4c07-881f-a9190c52c59a
          © 2016 American Academy of Neurology
          History
          : 17 February 2016
          : 22 July 2016
          Funding
          Funded by: National Institute on Aging awards
          Award ID: K23AG049945, R01AG029232, N01AG62101, N01AG62103, and N01AG 62106
          Funded by: NIH
          Award ID: P30 AG024827, P50 AG005133
          Categories
          54
          120
          Article

          Comments

          Comment on this article